|
Science 37 Holdings Inc (NASDAQ: SNCE) |
|
Science 37 Holdings Inc
SNCE's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Science 37 Holdings Inc growth rates, revenue grew
in III. Quarter 2023 from the same quarter a year ago.
Ranking at No. 3139
Medical Laboratories industry recorded
growth of revenues by 4.32 %
Science 37 Holdings Inc faced net loss in contrast to the net income a year ago in III. Quarter 2023
• More on SNCE's Growth
|
|
Science 37 Holdings Inc current PE on trailing twelve month basis is above Medical Laboratories industry average.
Science 37 Holdings Inc PEG ratio is at -0.02
Science 37 Holdings Inc realized cash reduction of $ -11.83 per share in trailing twelve-month period. |
Company |
2.88 |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.64.
Medical Laboratories industry's Price to Sales ratio is at 2.1.
• More on SNCE's Valuation
|
|
|
|
|
Science 37 Holdings Inc current PE on trailing twelve month basis is above Medical Laboratories industry average.
Science 37 Holdings Inc PEG ratio is at -0.02
Science 37 Holdings Inc realized cash outflow of $ -11.83per share in trailing twelve-month period. |
Company |
2.88 |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.64.
Medical Laboratories industry's Price to Sales ratio is at 2.1.
Science 37 Holdings Inc Price to Book Ratio is at 0.66 lower than Industry Avg. of 141.93. and higher than S&P 500 Avg. of 0.01
• More on SNCE's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com